Menu
06/02/2006
Cancer drug refusal branded a 'death sentence'
A woman who has launched a landmark legal challenge to get breast cancer drug Herceptin, has compared her NHS Trust's refusal to provide the drug as a "death sentence".
Ann Marie Rogers, 54, from Swindon launched the case after being refused the drug by Swindon Primary Care Trust, which is only licensed for the treatment of advanced breast cancer.
She had borrowed £5,000 for Herceptin treatment, but cannot afford to fund further courses.
Launching the case at the High Court, Ms Rogers' solicitor Ian Wise said that the Trust's policy of only providing Herceptin in "exceptional cases" was "arbitrary and unlawful".
In a statement, Ms Rogers said that she felt "as though I have been given a punishment like a death sentence" and added that "waiting for the cancer to return is like waiting on death row".
Pressure has been mounting on the NHS to provide Herceptin for patients in the early stages of breast cancer. In two other previous cases, the NHS agreed to provide the drug, which costs around £20,000 per year's treatment.
Ms Rogers' case is the first case to come to court. If she wins, it could lead to all PCTs being forced to provide the drug for all patients with early-stage breast cancer.
(KMcA)
Ann Marie Rogers, 54, from Swindon launched the case after being refused the drug by Swindon Primary Care Trust, which is only licensed for the treatment of advanced breast cancer.
She had borrowed £5,000 for Herceptin treatment, but cannot afford to fund further courses.
Launching the case at the High Court, Ms Rogers' solicitor Ian Wise said that the Trust's policy of only providing Herceptin in "exceptional cases" was "arbitrary and unlawful".
In a statement, Ms Rogers said that she felt "as though I have been given a punishment like a death sentence" and added that "waiting for the cancer to return is like waiting on death row".
Pressure has been mounting on the NHS to provide Herceptin for patients in the early stages of breast cancer. In two other previous cases, the NHS agreed to provide the drug, which costs around £20,000 per year's treatment.
Ms Rogers' case is the first case to come to court. If she wins, it could lead to all PCTs being forced to provide the drug for all patients with early-stage breast cancer.
(KMcA)
Related UK National News Stories
Click here for the latest headlines.
07 February 2006
Breast cancer sufferer faces wait on drug ruling
A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin. Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
Breast cancer sufferer faces wait on drug ruling
A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin. Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.
09 June 2006
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
Herceptin approved for early breast cancer use on NHS
Breast cancer drug Herceptin has been approved for the treatment of early stage breast cancer on the NHS by the National Institute for Health and Clinical Excellence. Herceptin is effective on the HER2 positive form of breast cancer, which forms around 20% of all breast cancer cases.
24 May 2006
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
Herceptin granted UK license
Breast cancer drug Herceptin has been licensed for use in the early stages of the disease in the UK by the European Medicines Agency. The drug, which is already used in Britain to treat the later stages of breast cancer, will now be appraised by the National Institute of Health and Clinical Excellence to see if it is safe and cost-effective.
12 April 2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
05 October 2005
Breast cancer drug to be fast-tracked
Health Secretary Patricia Hewitt has announced that all breast cancer sufferers will have the opportunity to be treated with the drug, Herceptin.
Breast cancer drug to be fast-tracked
Health Secretary Patricia Hewitt has announced that all breast cancer sufferers will have the opportunity to be treated with the drug, Herceptin.
-
Northern Ireland WeatherThis Evening and Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Perhaps a touch of ground frost. Cloud will spread east towards morning. Minimum temperature 2 °C.
